MDT

86.85

+0.89%↑

A

120.94

-0.58%↓

VEEV

170.07

+1.29%↑

HQY

86.03

+0.12%↑

NEOG

9.56

+0.63%↑

MDT

86.85

+0.89%↑

A

120.94

-0.58%↓

VEEV

170.07

+1.29%↑

HQY

86.03

+0.12%↑

NEOG

9.56

+0.63%↑

MDT

86.85

+0.89%↑

A

120.94

-0.58%↓

VEEV

170.07

+1.29%↑

HQY

86.03

+0.12%↑

NEOG

9.56

+0.63%↑

MDT

86.85

+0.89%↑

A

120.94

-0.58%↓

VEEV

170.07

+1.29%↑

HQY

86.03

+0.12%↑

NEOG

9.56

+0.63%↑

MDT

86.85

+0.89%↑

A

120.94

-0.58%↓

VEEV

170.07

+1.29%↑

HQY

86.03

+0.12%↑

NEOG

9.56

+0.63%↑

Search

Omnicell Inc

Ouvert

SecteurSoins de santé

38.12 -0.13

Résumé

Variation du prix de l'action

24h

Actuel

Min

37

Max

38.8

Chiffres clés

By Trading Economics

Revenu

-7.5M

-2M

Ventes

3.4M

314M

P/E

Moyenne du Secteur

875.25

63.808

Marge bénéficiaire

-0.645

Employés

3,580

EBITDA

-9.8M

21M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+50.86% upside

Dividendes

By Dow Jones

Prochains Résultats

28 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-646M

1.6B

Ouverture précédente

38.25

Clôture précédente

38.12

Sentiment de l'Actualité

By Acuity

50%

50%

135 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Omnicell Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 avr. 2026, 23:48 UTC

Principaux Événements d'Actualité

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19 avr. 2026, 23:36 UTC

Principaux Événements d'Actualité

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19 avr. 2026, 22:47 UTC

Principaux Événements d'Actualité

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19 avr. 2026, 21:14 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19 avr. 2026, 21:14 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19 avr. 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19 avr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19 avr. 2026, 23:38 UTC

Principaux Événements d'Actualité

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19 avr. 2026, 23:36 UTC

Market Talk
Principaux Événements d'Actualité

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19 avr. 2026, 23:12 UTC

Principaux Événements d'Actualité

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19 avr. 2026, 23:10 UTC

Principaux Événements d'Actualité

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19 avr. 2026, 23:09 UTC

Principaux Événements d'Actualité

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19 avr. 2026, 23:08 UTC

Principaux Événements d'Actualité

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18 avr. 2026, 01:00 UTC

Principaux Événements d'Actualité

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 avr. 2026, 22:58 UTC

Résultats

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 avr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 avr. 2026, 20:52 UTC

Résultats

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 avr. 2026, 20:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 avr. 2026, 20:29 UTC

Résultats

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Comparaison

Variation de prix

Omnicell Inc prévision

Objectif de Prix

By TipRanks

50.86% hausse

Prévisions sur 12 Mois

Moyen 57.75 USD  50.86%

Haut 70 USD

Bas 49 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

5

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

24.23 / 30.44Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

135 / 348Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat